Accumulating evidence has reported that the differential expression of DRAIC in prostate cancer, lung cancer, glioma, breast cancer, colorectal cancer, esophageal cancer, gastric cancer, nasopharyngeal carcinoma, and retinoblastoma. The gene discussed is DRAIC; the disease is prostate cancer.